<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.jabfm.org">
<title>JABFM current issue</title>
<link>http://www.jabfm.org</link>
<description>JABFM RSS feed -- current issue</description>
<prism:eIssn>1558-7118</prism:eIssn>
<prism:coverDisplayDate>November-December 2008</prism:coverDisplayDate>
<prism:publicationName>The Journal of the American Board of Family Medicine</prism:publicationName>
<prism:issn>1557-2625</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/483?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/485?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/487?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/490?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/497?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/504?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/512?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/522?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/531?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/539?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/549?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/555?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/562?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/569?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/575?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/content/abstract/21/6/577?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/580?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/580-a?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/580-b?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/581?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/582?rss=1" />
  <rdf:li rdf:resource="http://www.jabfm.org/cgi/reprint/21/6/583?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.jabfm.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.jabfm.org/icons/banner/title.gif">
<title>The Journal of the American Board of Family Medicine</title>
<url>http://www.jabfm.org/icons/banner/title.gif</url>
<link>http://www.jabfm.org</link>
</image>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/483?rss=1">
<title><![CDATA[Chronic Disease: Increasing Prevalence Yet Better Control]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/483?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Bowman, M. A., Neale, A. V.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080194</dc:identifier>
<dc:title><![CDATA[Chronic Disease: Increasing Prevalence Yet Better Control]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>484</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>483</prism:startingPage>
<prism:section>Editors' Note</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/485?rss=1">
<title><![CDATA[JABFM Revises Patient Consent Policy]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/485?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Neale, A. V., Bowman, M. A., Lupo, P.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080196</dc:identifier>
<dc:title><![CDATA[JABFM Revises Patient Consent Policy]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>486</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>485</prism:startingPage>
<prism:section>Editorial Office News And Notes</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/487?rss=1">
<title><![CDATA[The Gordian Knot of Chronic Illness Care]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/487?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Parchman, M. L.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080180</dc:identifier>
<dc:title><![CDATA[The Gordian Knot of Chronic Illness Care]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>489</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>487</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/490?rss=1">
<title><![CDATA[Characteristics of Diabetics with Poor Glycemic Control Who Achieve Good Control]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/490?rss=1</link>
<description><![CDATA[ 
<P><I>Objective:</I> To find the characteristics of diabetics with poorly controlled diabetes that became well controlled compared with the patients with poorly controlled diabetes that remained poorly controlled.</P>
 
<P><I>Methods:</I> The sample included diabetic patients, aged 40 years and older, from the Central district of Clalit Health Service in Israel, with at least one HbA1c measure greater than 9.5 mg% during 2001. They were divided into 2 categories according to their HbA1c levels in 2003, well controlled (HbA1c &lt;7.5 mg%) and poorly controlled (HbA1c &gt;9.5 mg%). Patients with 7.5&lt; HbA1c &lt;9.5 in 2003 were excluded from analysis.</P>
 
<P><I>Results:</I> Two thousand sixty-two diabetic patients met the inclusion criteria and care was provided by one of 249 primary care physicians. Of these patients, 1232 (41.6%) had well-controlled diabetes and 1760 (58.4%) had poorly controlled diabetes in 2003. The well-controlled group had fewer patients with low socioeconomic status (30.3% vs 41.9%; <I>P</I> &lt; .001) and more men (52% vs 43.8%; <I>P</I> &lt; .001). The individual primary care physician was the most significant predictor of good glycemic control. Total patient costs in 2004 were 8% lower among the group with well-controlled diabetes.</P>
 
<P><I>Conclusion:</I> The primary care physician has an important role in the patient's chances of achieving glycemic control. Further investigation of how and why some primary care physicians achieve better diabetes control in their patients would be worthwhile.</P>
]]></description>
<dc:creator><![CDATA[Shani, M., Taylor, T. R., Vinker, S., Lustman, A., Erez, R., Elhayany, A., Lahad, A.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.070267</dc:identifier>
<dc:title><![CDATA[Characteristics of Diabetics with Poor Glycemic Control Who Achieve Good Control]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>496</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>490</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/497?rss=1">
<title><![CDATA[The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/497?rss=1</link>
<description><![CDATA[ 
<P><I>Objective:</I> The aim of this study was to examine the relationship of hepatitis antibodies and liver enzymes with impaired fasting glucose and undiagnosed diabetes in adults.</P>
 
<P><I>Methods:</I> We analyzed the National Health and Nutrition Examination Survey, 1999 to 2004, a nationally representative sample of the noninstitutionalized US population. Among adults (aged &ge;20 years of age) who were not problem drinkers, we examined hepatitis B and C antibodies and the liver enzymes aspartate aminotransferase (AST), alanine aminotransferase (ALT), and glutamyl transaminase (GGT) with impaired fasting glucose and undiagnosed diabetes (unweighted, n = 5234; weighted, n = 172,626,805). Logistic regression models were computed controlling for major risk factors that drive diabetes screening, including age, gender, race, diagnosed hypertension, diagnosed hypercholesterolemia, and obesity.</P>
 
<P><I>Results:</I> In unadjusted analyses 51% of individuals with undiagnosed diabetes have elevated GGT versus 20% of individuals without diabetes or impaired fasting glucose (<I>P</I> = .01). Similarly, 43% of individuals with undiagnosed diabetes have elevated ALT versus 23% of individuals without diabetes or impaired fasting glucose (<I>P</I> = .01). AST and Hepatitis C antibodies were not associated with undiagnosed diabetes. In adjusted analyses, elevated GGT (odds ratio, 2.15; 95% CI, 1.44&ndash;3.20) and ALT (odds ratio, 1.84; 95% CI, 1.06&ndash;3.20) are associated with undiagnosed diabetes. Similarly, in adjusted analyses, elevated GGT (odds ratio, 1.23; 95% CI, 1.00&ndash;1.53) and ALT (odds ratio, 1.44; 95% CI, 1.15&ndash;1.79) are associated with impaired fasting glucose. Hepatitis antibodies, reporting a current liver problem, or AST were associated with having undiagnosed diabetes in adjusted analyses.</P>
 
<P><I>Conclusions:</I> Liver function is associated with undiagnosed diabetes and impaired fasting glucose and may justify further investigation as a risk stratification variable for undiagnosed diabetes or impaired fasting glucose.</P>
]]></description>
<dc:creator><![CDATA[Mainous, A. G., Diaz, V. A., King, D. E., Everett, C. J., Player, M. S.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080047</dc:identifier>
<dc:title><![CDATA[The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>503</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>497</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/504?rss=1">
<title><![CDATA[Hypertension in a Population of Active Duty Service Members]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/504?rss=1</link>
<description><![CDATA[ 
<P><I>Background:</I> Hypertension is a common condition, but little is known about its prevalence in the Armed Forces. Our purpose was to provide an estimate of the prevalence of hypertension in a large population of US service members.</P>
 
<P><I>Methods:</I> We reviewed the screening records for service members who completed health risk assessments at Fort Lewis in Tacoma, WA, in 2004. The prevalence of hypertension and prehypertension were estimated from single recorded blood pressure readings and subjects&rsquo; reported use of blood pressure medications. Study subject characteristics associated with hypertension and prehypertension were examined by <SUP>2</SUP> tests and multivariate logistic regression.</P>
 
<P><I>Results:</I> Thirteen percent of the 15,391 subjects met the study definition for hypertension; 62% met the study definition for prehypertension. Increasing age and body mass index, male sex, black race/ethnicity, and senior rank were associated with hypertension; only body mass index, male sex, and senior rank were associated with prehypertension.</P>
 
<P><I>Conclusion:</I> Hypertension and prehypertension are more prevalent in the US Armed Forces than has been previously reported, and prehypertension may be more common in the US Armed forces than in the general population. The high prevalence of prehypertension found in this young, fit population suggests a need to better define the risks and benefits associated with the diagnosis and treatment of prehypertension in low-risk populations.</P>
]]></description>
<dc:creator><![CDATA[Smoley, B. A., Smith, N. L., Runkle, G. P.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.070182</dc:identifier>
<dc:title><![CDATA[Hypertension in a Population of Active Duty Service Members]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>511</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>504</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/512?rss=1">
<title><![CDATA[Blood Pressure Control and Pharmacotherapy Patterns in the United States Before and After the Release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) Guidelines]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/512?rss=1</link>
<description><![CDATA[ 
<P><I>Objectives:</I> Despite recommendations from the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7), only 36.8% of patients were at target blood pressure (BP) in 2003 and 2004. The objective of this study was to assess improvements in BP control and treatment patterns before and after the publication of JNC 7.</P>
 
<P><I>Methods:</I> This was a retrospective, time series analysis of 27 provider groups and managed care organizations from 1998 through 2006. Patients with hypertension were identified from more than 4000 physicians. Medical charts were collected and clinical data were evaluated using prevailing JNC criteria during the time period before and after JNC 7.</P>
 
<P><I>Results:</I> A total of 19,258 patients were identified with hypertension: 15,258 included in the before-JNC 7 cohort and 4,000 in the after-JNC 7 cohort. BP control in the before-JNC 7 cohort was 40.8% compared with 49.3% in the after-JNC 7 cohort (<I>P</I> &lt; .0001). After controlling for demographic and clinical covariates, patients in the before-JNC 7 cohort were 45% less likely to achieve BP control compared with the after-JNC 7 cohort (odds ratio, 0.551; <I>P</I> &lt; .0001).</P>
 
<P><I>Conclusion:</I> Although findings indicate BP control is improving, a significant need for further improvement remains.</P>
]]></description>
<dc:creator><![CDATA[Jackson, J. H., Sobolski, J., Krienke, R., Wong, K. S., Frech-Tamas, F., Nightengale, B.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080025</dc:identifier>
<dc:title><![CDATA[Blood Pressure Control and Pharmacotherapy Patterns in the United States Before and After the Release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) Guidelines]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>521</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>512</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/522?rss=1">
<title><![CDATA[Improving Chronic Kidney Disease Care in Primary Care Practices: An Upstate New York Practice-based Research Network (UNYNET) Study]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/522?rss=1</link>
<description><![CDATA[ 
<P><I>Background:</I> With the prevalence of chronic kidney disease (CKD) in the United States rising from 10% to 13%, implementation of the evidence-based Kidney Disease Outcomes Quality Initiative guidelines, which were developed for the delay of progression of CKD, is of increasing importance in primary care offices. Previous studies have shown limited knowledge and uptake of Kidney Disease Outcomes Quality Initiative guidelines by primary care physicians. CKD and its complications are still largely under-diagnosed and under-treated. A multifaceted quality improvement study was undertaken to test if these guidelines could be implemented to improve CKD care in underserved practices.</P>
 
<P><I>Methods:</I> Using a combination of practice enhancement assistants, computer decision-making support, and academic detailing, we sought to increase physician awareness and care of CKD in 2 inner-city practices. Using these 3 modalities, a rapid-cycle quality improvement process was implemented.</P>
 
<P><I>Results:</I> One hundred eighty-one patients met the inclusion criteria of having a glomerular filtration rate &lt;60. This represented a 100% sample of patients with CKD at baseline. Recognition of CKD improved significantly from 30 (21%) to 114 (79%) (<I>P</I> &lt; .001). Diagnosis of anemia also increased significantly from 26 (33%) to 53 (67%) (<I>P</I> &lt; .001). Angiotensin-converting enzyme inhibitor and aspirin use did not change significantly (<I>P</I> = .31 and <I>P</I> = .233, respectively). Changes in medications that did show significance were metformin use, which decreased 50% from 12 to 6 patients (<I>P</I> &lt; .001), and nonsteroidal anti-inflammatory drug use, which decreased 41% from 23 to 14 patients (<I>P</I> &lt; .001). Mean glomerular riltration rate increased significantly from 45.75 to 47.34 (<I>P</I> &lt; .001).</P>
 
<P><I>Discussion:</I> Recognition and treatment of CKD and its complications can be markedly improved in primary care offices using a combination of practice enhancement assistants, computer decision-making support, and academic detailing. A significant rise in glomerular riltration rate, although small, was a surprising and encouraging result. Larger studies in a more geographically spread region are needed to confirm these preliminary results.</P>
]]></description>
<dc:creator><![CDATA[Fox, C. H., Swanson, A., Kahn, L. S., Glaser, K., Murray, B. M.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080042</dc:identifier>
<dc:title><![CDATA[Improving Chronic Kidney Disease Care in Primary Care Practices: An Upstate New York Practice-based Research Network (UNYNET) Study]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>530</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>522</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/531?rss=1">
<title><![CDATA[Predictive Value of Exercise Stress Testing in a Family Medicine Population]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/531?rss=1</link>
<description><![CDATA[ 
<P><I>Purpose:</I> Exercise stress testing (EST) is a screening test for coronary artery disease. Previous studies from the cardiology literature show an overall sensitivity of 67% and specificity of 72% with variable predictive values depending on pretest probability. The purpose of the current study was to evaluate the predictive value of EST in a family medicine population in eastern North Carolina.</P>
 
<P><I>Methods:</I> This is a retrospective case series of 339 ESTs performed in a family medicine center from July 2001 to April 2005. EST results were classified as positive, negative, or equivocal. Outcomes studied from a review of outpatient and inpatient electronic medical record data and telephone follow-up included myocardial infarction, cardiac catheterization with angioplasty and stenting, coronary artery bypass grafting, a new diagnosis of coronary artery disease, and cardiac death. Mean duration of follow-up was 47 months, with a range of 27 to 72 months.</P>
 
<P><I>Results:</I> Nearly all patients had low to intermediate risk pretest probability. Five tests were positive, 32 were equivocal, and 302 were negative. There were 2 false-positive tests, both in female patients. There were 2 false-negative tests, both of which were treated with good outcomes. Two of 32 equivocal results had cardiac outcomes. Considering equivocal tests as positive, the overall sensitivity in this series was 71.4%; specificity was 90.4%. The positive predictive value was 13.5% and the negative predictive value was 99.3%.</P>
 
<P><I>Conclusions:</I> The high negative predictive value for EST in this outpatient family medicine population is noteworthy and reassuring. EST is a cost-effective strategy for triaging the common complaint of chest pain in low- to intermediate-risk patients in primary care practices and should be included in the services offered to family medicine patients.</P>
]]></description>
<dc:creator><![CDATA[Newman, R. J., Darrow, M., Cummings, D. M., King, V., Whetstone, L., Kelly, S., Jalonen, E.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.070257</dc:identifier>
<dc:title><![CDATA[Predictive Value of Exercise Stress Testing in a Family Medicine Population]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>538</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>531</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/539?rss=1">
<title><![CDATA[Creating a Clinical Screening Questionnaire for Eating Behaviors Associated with Overweight and Obesity]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/539?rss=1</link>
<description><![CDATA[ 
<P><I>Objective:</I> The objective of this study was to associate questions about specific eating behaviors with weight. Our ultimate goal was to create a clinical screening questionnaire for eating behaviors associated with overweight and obesity.</P>
 
<P><I>Methods:</I> We developed a questionnaire based on eating behaviors associated with overweight and obesity. After pilot testing and revision, we administered the questionnaire to patients in 2 primary care clinics from the Utah Health Research Network. We analyzed the relationship between measured body mass index, demographic factors, and responses to screening questions about eating behaviors and physical activity.</P>
 
<P><I>Results:</I> We collected 261 completed questionnaires with weight and height measurements. With regression analysis, questions about consumption of beverages with sugar added, fruits and vegetables, and full portions served at restaurants as well as questions about physical activity were associated with body mass index and being overweight and/or obese.</P>
 
<P><I>Conclusions:</I> We suggest that future research about eating behaviors focus on the questions regarding typical consumption of beverages with sugar added, fruits and vegetables, and full portions served at restaurants to further develop a tool for clinical screening.</P>
]]></description>
<dc:creator><![CDATA[Greenwood, J. L. J., Murtaugh, M. A., Omura, E. M., Alder, S. C., Stanford, J. B.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.070265</dc:identifier>
<dc:title><![CDATA[Creating a Clinical Screening Questionnaire for Eating Behaviors Associated with Overweight and Obesity]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>548</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>539</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/549?rss=1">
<title><![CDATA[Grandparental and Parental Obesity Influences on Childhood Overweight: Implications for Primary Care Practice]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/549?rss=1</link>
<description><![CDATA[ 
<P><I>Background:</I> Community-based studies have suggested a multigenerational pattern of obesity affecting children's risk of overweight, but no national data have substantiated such a pattern. Our objective was to examine the prevalence of overweight [body mass index (BMI) &ge;95th percentile for age and sex] among children aged 5 to 19 in a national sample, stratified by the obesity status of their parents and grandparents.</P>
 
<P><I>Methods:</I> We used a secondary analysis of the Panel Study of Income Dynamics, Child Development Supplement, a multigenerational, genealogical, prospective cohort study of the US population. Self-report height and weight data from adults and measured height and weight data for children were used to calculate BMI. The prevalence of child overweight was calculated for different possible combinations of parental and grandparental BMI status, including missing status.</P>
 
<P><I>Results:</I> The sample included 2591 children aged 5 to 19 years, for whom parental BMI data were available for 94% and grandparental BMI data were available for 61%. Prevalence of childhood overweight (18.6%) in the sample was comparable with contemporaneous measured national data from other sources. Among children with normal-weight parents and normal-weight grandparents, 7.9% were overweight. In contrast, among children with overweight parents (BMI 25&ndash;29.9) and normal-weight grandparents, 17.9% were overweight, and among children with obese parents (BMI &ge;30) and normal-weight grandparents, 31.9% were overweight (<I>P</I> &lt; .0001). Importantly, when parents were normal weight, if grandparents were obese, then the prevalence of child overweight was 17.4% (<I>P</I> &lt; .0001). The prevalence of child overweight was similarly elevated (16.4%) when parents were normal weight and grandparental BMI was missing.</P>
 
<P><I>Conclusions:</I> This is the first national study to find an association of child weight status with grandparental obesity, distinct from parental obesity. Primary care physicians may find it helpful to consider grandparents&rsquo; weight status in judging risk of childhood overweight for their patients, especially when parents&rsquo; weight is normal.</P>
]]></description>
<dc:creator><![CDATA[Davis, M. M., McGonagle, K., Schoeni, R. F., Stafford, F.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.070140</dc:identifier>
<dc:title><![CDATA[Grandparental and Parental Obesity Influences on Childhood Overweight: Implications for Primary Care Practice]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>554</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>549</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/555?rss=1">
<title><![CDATA[Perception, Intention, and Action in Adolescent Obesity]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/555?rss=1</link>
<description><![CDATA[ 
<P><I>Background:</I> Insight into adolescents&rsquo; weight-loss behavior is needed.</P>
 
<P><I>Methods:</I> Survey data were obtained from overweight and obese adolescents in the Youth Risk Behavioral Survey (YRBS) in Delaware. Cross tabulations were used to determine the frequency of accurate perception, recent action, and current intention regarding weight loss. Multivariable analysis identified factors associated with recent action to lose weight.</P>
 
<P><I>Results:</I> From 2728 records, 482 overweight adolescents and 398 obese adolescents were identified. Most obese (83%) and overweight (79%) adolescents reported recent action to lose weight. Most obese (75%) and overweight (65%) adolescents intended to lose weight. Obese and overweight adolescents who reported a current intention to lose weight were more likely to have taken recent action to lose weight (odds ratio [OR], 11.6 and 6.6, respectively).</P>
 
<P><I>Conclusions:</I> The percentage of obese and overweight adolescents who have an accurate perception of weight, intend to lose weight, and have taken recent action to lose weight suggests that this group is highly engaged in weight-related behavior change. Compared with their obese peers, overweight adolescents seem less engaged in weight change behavior. There is a strong association in both groups between intention and recent action, and this association indicates that obese and overweight adolescents are highly motivated to change their weight.</P>
]]></description>
<dc:creator><![CDATA[Bittner Fagan, H., Diamond, J., Myers, R., Gill, J. M.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.070184</dc:identifier>
<dc:title><![CDATA[Perception, Intention, and Action in Adolescent Obesity]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>561</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>555</prism:startingPage>
<prism:section>Original Research</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/562?rss=1">
<title><![CDATA[Obesity: Effects on Cardiovascular Disease and its Diagnosis]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/562?rss=1</link>
<description><![CDATA[ 
<P>The higher prevalence of cardiovascular disease in obese individuals is indirectly mediated, to a large extent, by the increased frequency of various well known risk factors like hypertension, diabetes, and dyslipidemia, either individually or as part of the metabolic syndrome. However, there are several ways in which obesity directly affects the cardiovascular system; these will be discussed in detail. We also focus on various challenges posed by obesity in the performance and interpretation of cardiac investigations and how they can be addressed.</P>
]]></description>
<dc:creator><![CDATA[Mathew, B., Francis, L., Kayalar, A., Cone, J.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080080</dc:identifier>
<dc:title><![CDATA[Obesity: Effects on Cardiovascular Disease and its Diagnosis]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>568</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>562</prism:startingPage>
<prism:section>Clinical Reviews</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/569?rss=1">
<title><![CDATA[Primary Care Approach to Proteinuria]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/569?rss=1</link>
<description><![CDATA[ 
<P>Proteinuria is a common finding in primary care practice. Most adolescents who are diagnosed with proteinuria through screening urinalysis do not have renal disease, and the proteinuria will usually resolve on repeat testing. In contrast, proteinuria is suggestive of kidney disease in patients with diabetes mellitus, hypertension, primary renal disease, or other systemic illnesses. Quantification of proteinuria can be used longitudinally to monitor therapeutic effects of treatment of the underlying disease. Given the multitude of clinical settings in which proteinuria can occur, we suggest an algorithm that may help clinicians differentiate between benign and serious etiologies of proteinuria.</P>
]]></description>
<dc:creator><![CDATA[Naderi, A. S. A., Reilly, R. F.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.070080</dc:identifier>
<dc:title><![CDATA[Primary Care Approach to Proteinuria]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>574</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>569</prism:startingPage>
<prism:section>Clinical Reviews</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/575?rss=1">
<title><![CDATA[Severe Deterioration of Metabolic Control Caused by Malfunction of a Disposable Insulin Pen Device]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/575?rss=1</link>
<description><![CDATA[ 
<P>This report describes the case of a 68-yr-old diabetic woman with severe deterioration of glycemic control caused by the use of a malfunctioning insulin pen device.</P>
]]></description>
<dc:creator><![CDATA[Boronat, M., Garcia-Delgado, Y., Perez-Martin, N., Novoa, F. J.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080052</dc:identifier>
<dc:title><![CDATA[Severe Deterioration of Metabolic Control Caused by Malfunction of a Disposable Insulin Pen Device]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>576</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>575</prism:startingPage>
<prism:section>Brief Reports</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/content/abstract/21/6/577?rss=1">
<title><![CDATA[Angioedema After Local Trauma in a Patient on Angiotensin-Converting Enzyme Inhibitor Therapy]]></title>
<link>http://www.jabfm.org/cgi/content/abstract/21/6/577?rss=1</link>
<description><![CDATA[ 
<P>Angioedema is a side effect that is often associated with the use of angiotensin-converting enzyme (ACE) inhibitor medications. These medications result in increased levels of circulating bradykinins. This case illustrates the result of a local traumatic event to the upper lip, presumably causing marked bradykinin release in a patient who was taking an ACE inhibitor. The local release of bradykinin from trauma, in addition to decreased bradykinin catabolism secondary to ACE inhibitor therapy, resulted in angioedema predominantly in the upper lip. The angioedema resolved with discontinuation of the ACE inhibitor.</P>
]]></description>
<dc:creator><![CDATA[Simmons, B. B., Folsom, M. A., Bryden, L. A., Studdiford, J. S.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080103</dc:identifier>
<dc:title><![CDATA[Angioedema After Local Trauma in a Patient on Angiotensin-Converting Enzyme Inhibitor Therapy]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>579</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>577</prism:startingPage>
<prism:section>Brief Reports</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/580?rss=1">
<title><![CDATA[Re: Pregnancy Care: An Apprenticeship for Palliative Care?]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/580?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Sinclair, C. T.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080132</dc:identifier>
<dc:title><![CDATA[Re: Pregnancy Care: An Apprenticeship for Palliative Care?]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>580</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>580</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/580-a?rss=1">
<title><![CDATA[Re: Improving Performance in Prevention]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/580-a?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Parrish, D. O.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080148</dc:identifier>
<dc:title><![CDATA[Re: Improving Performance in Prevention]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>581</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>580</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/580-b?rss=1">
<title><![CDATA[Response: Re: Pregnancy Care: An Apprenticeship for Palliative Care?]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/580-b?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Clark, W.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080160</dc:identifier>
<dc:title><![CDATA[Response: Re: Pregnancy Care: An Apprenticeship for Palliative Care?]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>580</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>580</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/581?rss=1">
<title><![CDATA[Response: Re: Improving Performance in Prevention]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/581?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Newton, W.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080179</dc:identifier>
<dc:title><![CDATA[Response: Re: Improving Performance in Prevention]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>581</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>581</prism:startingPage>
<prism:section>Correspondence</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/582?rss=1">
<title><![CDATA[Part IV Modules of Maintenance of Certification]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/582?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cattoi, R.]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080171</dc:identifier>
<dc:title><![CDATA[Part IV Modules of Maintenance of Certification]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>582</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>582</prism:startingPage>
<prism:section>Board News</prism:section>
</item>

<item rdf:about="http://www.jabfm.org/cgi/reprint/21/6/583?rss=1">
<title><![CDATA[Correction to "Outcomes From Treatment of Infertility With Natural Procreative Technology in an Irish General Practice"]]></title>
<link>http://www.jabfm.org/cgi/reprint/21/6/583?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-11-06</dc:date>
<dc:identifier>info:doi/10.3122/jabfm.2008.06.080191</dc:identifier>
<dc:title><![CDATA[Correction to "Outcomes From Treatment of Infertility With Natural Procreative Technology in an Irish General Practice"]]></dc:title>
<dc:publisher>American Board of Family Medicine</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>21</prism:volume>
<prism:endingPage>583</prism:endingPage>
<prism:publicationDate>2008-11-01</prism:publicationDate>
<prism:startingPage>583</prism:startingPage>
<prism:section>Erratum</prism:section>
</item>

</rdf:RDF>